Palatinal maxillary canine

K11_MAXIL_CANINE_PALAT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions K11_MAXIL_CANINE_OPER	349
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — K01, K07.35 Hospital discharge: ICD-10 — K01, K07.35 Cause of death: ICD-10 — K01, K07.35 3 out of 7 registries used, show all original rules.	284
4. Check minimum number of events None	284
5. Include endpoints None	284
6. Filter based on genotype QC (FinnGen only)	273

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	K11_MAXIL_CANINE_PALAT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	K11_MAXIL_CANINE_OPER
OUTPAT_ICD	K0735\|K01
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K0735\|K01
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K0735\|K01
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Palatinal maxillary canine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8262	5033	3229
Only index persons	8021	4893	3128
Unadjusted period prevalence (%)
Whole population	0.12	0.14	0.09
Only index persons	0.16	0.18	0.12
Median age at first event (years)
Whole population	-	12.56	12.85
Only index persons	12.74	12.63	12.92

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	273	211	62
Unadjusted period prevalence (%)	0.06	0.07	0.03
Median age at first event (years)	13.35	13.20	13.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
284: Matched controls
2840

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ECA00

NOMESCO Finland

Surgical exposure of tooth

11161.6

307.7

281

K01.12

ICD-10 Finland

Retained canine with obstruction in the upper jaw

92.0

195.2

105

K01.0

ICD-10 Finland

Embedded teeth

30.9

174.0

135

K07.35

ICD-10 Finland

Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth

37.5

140.9

SJD00

NOMESCO Finland

Removal and/or reactivation of orthodontic arch wire

10.8

93.4

170

345

SJD10

NOMESCO Finland

Placement of orthodontic arch wire

10.7

92.4

171

353

SJC01

NOMESCO Finland

Positioning and fixed attachment of single bracket (Bracket with fixed attachment)

10.3

89.6

159

311

SJC50

NOMESCO Finland

Removal of fixed orthodontic appliance with at least 7 brackets

7.8

66.1

139

312

SJD20

NOMESCO Finland

Placement of modified orthodontic arch wire

7.4

58.8

119

253

SJC02

NOMESCO Finland

Positioning and fixed attachment of brackets

6.7

46.3

196

SJC03

NOMESCO Finland

Positioning and fixed attachment of brackets, extensive

6.2

46.3

106

248

SBB10

NOMESCO Finland

Dental impressions

5.3

43.2

174

651

SJD40

NOMESCO Finland

Placement of prefabricated palatal or lingual arch

5.2

40.2

120

349

SJD30

NOMESCO Finland

Demanding placement of orthodontic arch wire

6.4

38.8

155

SJB00

NOMESCO Finland

Fitting of removable appliance incl. patient instructions

4.7

34.6

119

381

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

7.1

31.6

SJX21

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment

4.4

30.2

105

334

SJX10

NOMESCO Finland

Orthodontic treatment/control appointment, short

3.7

25.6

135

563

SJC10

NOMESCO Finland

Orthodontic band in one tooth

4.2

25.5

269

SXC05

NOMESCO Finland

Other oral or dental procedure

3.4

21.6

112

453

SJX11

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment, restricted

3.4

21.1

113

465

SAA04

NOMESCO Finland

Special examination of mouth

3.7

21.1

315

SAC02

NOMESCO Finland

Separate planning of oral and dental treatment, demanding

4.0

19.8

198

SJC40

NOMESCO Finland

Removal of fixed orthodontic appliance with at most 6 brackets

3.4

19.1

364

SJD50

NOMESCO Finland

Placement of prefabricated palatal or lingual arch, dentist-made

6.1

16.4

EB1MA

NOMESCO Finland

Cephalometry with X-ray

3.3

16.3

282

SAC01

NOMESCO Finland

Separate planning of oral and dental treatment, standard

3.4

16.1

255

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.0

15.8

199

1256

SJX20

NOMESCO Finland

Orthodontic treatment/control appointment

3.0

14.0

313

K07.30

ICD-10 Finland

Spacing, abnormal of tooth or teeth

2.9

13.9

339

EBA00

NOMESCO Finland

Extraction of tooth

2.6

13.4

186

1192

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.0

13.0

274

EMAK, ,

NOMESCO Finland

5.7

12.5

WZA90

NOMESCO Finland

Other medical or dental certificate

2.5

12.4

133

747

OIKH, ,

NOMESCO Finland

2.8

12.2

315

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.4

12.0

OIKAL, ,

NOMESCO Finland

3.6

11.6

131

OIKK, ,

NOMESCO Finland

2.4

9.8

441

SJC00

NOMESCO Finland

Bondable bracket or other fixed attachement

15.7

9.6

WX110

NOMESCO Finland

Infiltration anesthesia

3.3

9.6

253

2028

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.7

9.6

251

K07.25

ICD-10 Finland

Anomalies of dental arch relationship

3.0

9.4

173

K01.1

ICD-10 Finland

Impacted teeth

8.7

K01.19

ICD-10 Finland

Retained tooth with obstruction barrier UNS

92.7

8.5

K01.13

ICD-10 Finland

Retained canine with obstruction in the lower jaw

34.4

8.1

OIKRE, ,

NOMESCO Finland

4.6

7.8

K00.68

ICD-10 Finland

Other disturbance in the tooth eruption

3.1

7.8

119

K07.38

ICD-10 Finland

Other anomaly in the position of the teeth

3.3

7.7

SAA03

NOMESCO Finland

Extended examination of mouth

2.2

7.6

209

1599

K03.30

ICD-10 Finland

Internal granuloma of pulp

+∞

7.3

K01.10

ICD-10 Finland

Retained front tooth with obstruction in the upper jaw

30.9

7.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000492) Spirometry study

180

1.88

2.61

1.7

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

5.08

2.41

4.0

2.0

—

(36304419) Bacteria [Presence] in Urine

522

0.62

1.86

4.7

3.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.71

1.73

1.1

1.6

—

(3018133) Calcium [Moles/volume] in Urine

2.96

1.73

5.1

2.4

2.69

2.16

mmol/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

297

0.55

1.65

1.6

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.63

1.52

1.7

2.6

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

0.00

1.51

0.0

2.1

—

0.18

—

(3018095) Leukocytes [#/volume] in Urine

704

0.71

1.44

5.4

3.7

6.83

93.46

e6/l

3.38

441

(3048929) Epstein Barr virus Ab [Presence] in Serum

330

0.61

1.40

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

2.97

1.36

2.6

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.97

1.36

1.4

1.1

—

(3042733) HLA Ab [Presence] in Serum

2.97

1.36

4.8

3.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

455

1.37

1.32

3.4

2.3

2.38

mmol/l

0.06

409

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.81

1.29

1.4

1.1

—

(3045424) Erythrocytes [Presence] in Urine

2.33

1.19

1.5

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

748

0.75

1.18

2.5

2.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

151

0.52

1.18

1.3

1.5

—

(3000991) Gas panel - Venous blood

217

1.48

1.17

16.9

10.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2.53

1.15

5.6

6.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.93

1.13

8.3

9.9

0.60

0.68

0.38

(36660697) Celiac disease serology panel - Serum

323

1.39

1.13

1.3

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.90

1.09

14.2

14.6

0.63

0.68

0.29

(3009542) Hematocrit [Volume Fraction] of Blood

249

2584

0.70

1.07

16.5

12.4

39.53

40.06

0.77

233

2444

(3005033) Fetal Nuchal fold Thickness US

149

0.52

1.07

1.3

1.4

—

(3024928) Oxygen saturation in Venous blood

2.15

1.06

9.1

15.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

2.29

1.04

2.8

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

2.29

1.04

2.8

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.19

0.98

1.6

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

2.19

0.98

1.6

2.3

39.50

36.82

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

0.97

0.0

1.5

—

328.57

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

2.2

—

37877.42

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.25

0.94

1.0

—

(3026782) Osmolality of Urine

356

0.70

0.93

2.6

3.0

638.24

604.59

mosm/kgh2o

0.19

312

(3019230) Fractional oxyhemoglobin in Venous blood

2.17

0.92

9.5

16.0

71.00

65.96

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.17

0.92

1.3

1.1

0.81

24.52

u/ml

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.17

0.92

2.7

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.17

0.92

2.7

1.5

—

(3008898) HLA-B27 [Presence]

128

0.54

0.90

1.1

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

178

1.44

0.90

1.2

1.3

460.23

279.73

miu/ml

1.05

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.09

0.90

1.0

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

1.81

0.89

3.0

3.4

20.73

36.03

mu/l

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

284

0.68

0.87

1.4

1.2

1.23

8.68

u/ml

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.84

0.86

1.0

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.96

0.85

1.5

1.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

251

1.36

0.83

13.9

8.2

5.86

5.89

kpa

0.12

242

(3010813) Leukocytes [#/volume] in Blood

251

2589

0.74

0.83

15.8

12.1

6.76

6.79

e9/l

0.08

239

2496

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

130

1170

1.20

0.82

2.4

2.8

34.22

35.81

mmol/mol

1.91

124

1097

(3000963) Hemoglobin [Mass/volume] in Blood

251

2588

0.74

0.81

15.9

12.3

133.56

134.23

g/l

0.36

244

2543

(3047352) Trisomy 18 risk [Likelihood] in Fetus

149

0.59

0.81

1.2

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

725

1.23

0.80

12.3

8.6

1.22

mmol/l

0.37

644

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.51

0.79

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.84

0.79

1.0

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.84

0.79

1.0

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.84

0.79

1.5

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

2.4

—

5.32

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

115

1.51

0.79

23.1

14.9

1.28

1.07

mg/l

0.71

110

(3014007) Fractional oxyhemoglobin in Arterial blood

1.72

0.77

15.5

14.5

96.95

95.35

—

(3005322) IgE [Units/volume] in Serum or Plasma

202

1.37

0.76

1.3

349.76

354.09

u/ml

0.01

189

(3014576) Chloride [Moles/volume] in Serum or Plasma

142

1.44

0.74

12.2

8.8

105.55

105.35

mmol/l

0.13

142

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.86

0.74

2.4

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1.60

0.72

17.3

14.9

22.89

23.47

mmol/l

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.66

0.69

2.2

2.1

—

(4062490) Immunoglobulin typing, IgG

1.87

0.69

1.6

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.87

0.69

2.6

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

206

1.34

0.68

12.7

8.8

24.22

23.50

mmol/l

0.84

206

(4200892) Spirometry reversibility

1.51

0.68

1.2

1.4

—

(3003338) MCHC [Mass/volume]

205

2150

0.83

0.67

15.2

10.6

333.54

334.18

g/l

0.42

199

2120

(40761511) CBC panel - Blood by Automated count

225

2339

0.82

0.66

8.4

7.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

182

1925

0.85

0.64

12.5

8.3

3.86

3.85

mmol/l

0.31

168

1848

(3026361) Erythrocytes [#/volume] in Blood

252

2586

0.77

0.63

15.7

12.1

4.53

4.58

e12/l

0.96

241

2495

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1.65

0.62

1.1

1.6

8.59

6.56

mmol/l

—

(3024731) MCV [Entitic volume]

252

2585

0.78

0.61

15.6

12.1

88.26

87.73

1.19

245

2536

(3035941) MCH [Entitic mass]

252

2585

0.78

0.61

15.6

12.1

29.54

29.42

0.55

245

2536

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1.52

0.61

2.7

2.9

90.00

100.74

ml/min/173m2

—

(3015183) Erythrocyte sedimentation rate

0.00

0.60

0.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

497

1.21

0.60

3.9

2.7

1.01

kg/l

0.06

(3019550) Sodium [Moles/volume] in Serum or Plasma

183

1930

0.85

0.60

12.4

8.3

139.30

139.46

mmol/l

0.50

170

1861

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.58

0.59

2.5

2.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

207

0.71

0.59

1.8

1.9

55.03

6.63

u/l

—

160

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

0.00

0.58

0.0

3.2

—

121.09

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

585

0.82

0.58

4.3

3.5

—

(3013512) EKG study

273

0.75

0.58

1.9

2.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.50

0.57

1.9

2.0

—

(3000494) Fungus identified in Specimen by Culture

159

1.35

0.57

1.7

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.68

0.57

2.7

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

205

1.30

0.55

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

540

1.19

0.54

4.6

3.1

0.00

0.01

estimate

0.80

225

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.59

0.54

1.2

1.0

—

(3007461) Platelets [#/volume] in Blood

252

2580

0.79

0.54

15.7

12.2

270.10

265.73

e9/l

0.51

242

2491

(3017143) Hepatitis C virus Ab [Presence] in Serum

465

1.20

0.54

1.9

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

224

1.28

0.53

2.3

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.53

0.53

1.8

1.9

—

(3036180) Methadone [Presence] in Urine

1.51

0.52

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

630

0.84

0.51

2.2

2.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

108

1174

0.87

0.51

2.3

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1072

0.87

0.51

2.7

2.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

146

1554

0.88

0.50

7.0

5.7

108.80

112.11

ml/min/173m2

0.77

1069

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

107

0.65

0.49

1.3

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

1.57

0.49

1.3

2.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

236

1.25

0.49

14.8

7.8

5.38

4.88

kpa

0.55

228

(3044889) 12 lead EKG panel

946

0.87

0.48

2.4

2.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.50

0.48

1.9

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

201

2090

0.87

0.47

14.5

10.9

13.71

13.26

0.92

196

2051

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

677

0.86

0.47

1.5

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

118

0.67

0.47

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

147

1.31

0.46

2.2

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

235

2415

0.84

0.46

4.2

4.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

152

0.71

0.45

1.7

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

380

0.82

0.44

2.6

2.8

10.13

11.51

e6/l

0.20

336

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.38

0.44

16.7

24.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

194

2018

0.88

0.44

4.2

4.0

1.71

1.82

mu/l

0.91

183

1900

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

443

0.84

0.43

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

195

0.76

0.43

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

194

0.76

0.42

1.3

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

162

1538

1.12

0.41

2.4

2.2

5.14

5.34

mmol/l

3.55

155

1392

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

114

1.33

0.41

1.8

2.0

—

(1616796) Gas panel - Central venous blood

1.52

0.41

4.2

4.8

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.41

0.0

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.41

0.0

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1008

0.88

0.41

2.4

2.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

108

1160

0.89

0.41

10.5

6.2

32.28

32.43

0.06

101

1104

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

291

0.81

0.41

1.2

8.70

16.27

iu/ml

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.41

0.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.41

0.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.40

0.0

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

749

1.13

0.40

4.2

2.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.44

0.39

1.6

1.0

—

(3011288) Drugs identified in Urine by Screen method

268

0.81

0.39

1.2

2.2

—

(40768793) Breast Pathology biopsy report

0.00

0.39

0.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.39

0.0

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

2.4

—

17.18

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.8

—

3.36

—

(3021589) Normoblasts [#/volume] in Blood

100

1076

0.89

0.39

12.0

7.5

0.00

e9/l

-0.00

863

(3020891) Body temperature

1.40

0.38

3.6

4.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

113

0.70

0.38

1.0

1.5

2.30

3.83

ug/l

—

105

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

146

0.74

0.37

1.6

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

675

1.13

0.37

14.0

8.8

1.23

1.22

mmol/l

0.24

636

(3052851) Hemolysis interference index of Serum or Plasma

1.47

0.36

2.0

2.2

—

(3000330) Specific gravity of Urine by Test strip

0.65

0.36

3.0

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.44

0.36

1.7

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.40

0.35

1.3

1.1

—

(40761535) Cells panel - Urine sediment

100

1.31

0.34

4.4

3.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

296

1.17

0.32

1.6

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

186

0.80

0.32

2.3

2.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

120

1267

0.91

0.32

11.9

7.3

3.79

3.77

e9/l

0.03

101

1097

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.35

0.31

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

207

0.81

0.31

10.0

5.1

4.75

8.06

umol/l

0.80

166

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

279

1.17

0.30

1.1

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.28

0.30

2.6

2.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

148

1.23

0.30

2.2

1.6

—

(40758558) Short blood count panel - Blood

541

0.89

0.29

10.4

5.9

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

194

0.81

0.28

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

194

0.81

0.28

1.3

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

149

1.22

0.28

1.4

1.6

1047.36

1000.97

nmol/l

0.07

117

(3019198) Lymphocytes [#/volume] in Blood

113

1191

0.91

0.28

10.5

6.3

2.06

2.05

e9/l

0.10

100

1066

(46235355) HIV 1 and 2 tests - Meaningful Use set

104

1100

0.91

0.28

2.3

2.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

136

1420

0.92

0.27

3.7

7.11

7.45

mm/h

0.20

128

1303

(3007853) Bacteria identified in Skin by Aerobe culture

235

1.16

0.26

1.7

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

224

0.84

0.26

1.2

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

108

1137

0.92

0.26

10.3

6.0

53.08

53.69

0.22

101

1079

(4035726) Immunohistochemistry procedure

1.22

0.25

1.2

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

463

0.89

0.25

2.0

2.9

156.07

75.50

ug/g

0.42

340

(3041096) Erythrocytes [Presence] in Urine by Automated

594

1.10

0.24

3.0

2.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

228

1.15

0.23

16.7

11.1

24.45

24.92

mmol/l

0.34

228

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

106

1.24

0.23

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

116

1213

0.93

0.23

7.2

4.9

87.45

86.48

u/l

0.07

110

1128

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

218

2225

0.91

0.23

10.5

8.6

21.84

21.40

mg/l

0.06

159

1563

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

175

1801

0.93

0.23

3.7

3.5

14.27

14.33

pmol/l

0.12

157

1603

(3021879) Hepatitis B virus core Ab [Presence] in Serum

273

0.87

0.22

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

199

0.84

0.22

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

816

0.92

0.21

2.0

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

448

0.90

0.21

4.0

1.01

1.05

inr

1.04

169

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.0

—

1.86

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

5.2

—

10.32

—

(21494434) Karyotype in Bone marrow

0.00

0.21

0.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.25

0.21

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.20

0.0

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

208

2122

0.93

0.20

8.8

6.6

23.60

23.75

u/l

0.04

197

2027

(40768804) Tissue Pathology biopsy report

513

1.09

0.19

2.0

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.16

0.19

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.16

0.19

1.0

—

(40761536) Microorganisms panel - Urine sediment

216

0.87

0.18

4.2

3.3

—

(3022621) pH of Urine by Test strip

119

1.19

0.18

2.1

2.0

—

(40768443) Skin Pathology biopsy report

1.17

0.18

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

526

1.08

0.17

1.6

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.72

0.17

1.8

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

214

0.88

0.16

1.8

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

547

1.08

0.16

3.0

2.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

168

1.14

0.16

1.7

2.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.10

0.16

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.79

0.16

1.2

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.21

0.15

1.6

1.7

—

(3002256) Pathology report gross observation

161

0.86

0.15

1.2

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.11

0.15

1.1

1.4

—

(3018418) pH of Serum or Plasma

383

1.08

0.14

9.8

3.0

7.38

7.39

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.83

0.14

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

128

0.85

0.14

2.9

2.5

—

(3003694) ABO and Rh group [Type] in Blood

893

0.95

0.13

1.7

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

277

1.09

0.13

1.2

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

799

1.05

0.13

1.5

1.74

g/l

0.02

459

(3021601) Nitrite [Presence] in Urine by Test strip

103

998

1.05

0.12

5.9

4.1

0.00

estimate

-0.00

229

(3011397) Hemoglobin [Presence] in Urine by Test strip

465

0.94

0.12

5.5

2.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

201

1.10

0.12

5.2

6.6

1.20

1.05

mmol/l

0.09

135

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

898

0.96

0.11

3.1

2.7

—

(3035350) Ketones [Presence] in Urine by Test strip

103

1002

1.04

0.10

4.4

3.0

0.00

estimate

-0.00

228

(3001122) Ferritin [Mass/volume] in Serum or Plasma

132

1292

1.04

0.10

3.0

2.8

49.81

44.98

ug/l

0.30

126

1204

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

674

0.95

0.09

9.5

5.4

9.72

10.45

umol/l

0.28

611

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

331

1.07

0.09

1.9

7.17

14.13

ng/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

196

0.91

0.09

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

103

1005

1.04

0.09

4.5

3.1

0.00

estimate

-0.00

224

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

107

1.13

0.08

2.4

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

234

1.07

0.08

1.6

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.05

0.08

1.3

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

324

1.06

0.07

1.7

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.83

0.07

1.3

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

790

0.97

0.07

1.7

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

187

1.07

0.06

4.6

2.8

17.23

24.11

2.00

170

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

426

0.96

0.06

3.3

2.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

999

0.97

0.06

6.5

5.4

5.94

mmol/l

0.00

860

(3006504) Eosinophils/100 leukocytes in Blood

106

1079

0.97

0.06

10.5

6.5

2.83

2.79

0.05

1016

(3019069) Monocytes/100 leukocytes in Blood

107

1088

0.97

0.05

10.5

6.7

8.07

8.02

0.07

1029

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.12

0.05

1.5

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

142

1402

1.03

0.05

4.9

3.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

159

1.07

0.05

6.0

6.6

10.24

9.91

kpa

0.29

150

(3022313) Gas panel - Capillary blood

169

1.07

0.05

5.6

6.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

120

1.09

0.05

2.8

2.2

—

(3025941) Bacteria identified in Stool by Culture

130

0.92

0.04

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

407

1.04

0.04

2.0

2.4

3595.05

5946.95

u/l

0.41

150

(3015736) pH of Urine

825

1.03

0.04

4.4

2.7

6.44

6.11

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

150

0.93

0.04

1.1

1.2

—

(3013115) Eosinophils [#/volume] in Blood

114

1155

0.98

0.04

11.2

6.8

0.17

0.18

e9/l

0.26

1023

(3023323) Follitropin [Units/volume] in Serum or Plasma

170

1.06

0.04

1.7

1.9

45.74

6.73

iu/l

—

129

(3027944) Amphetamines [Presence] in Urine

398

1.04

0.04

1.7

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

111

1.08

0.04

1.6

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

111

1.08

0.04

10.1

4.8

144.92

171.60

0.57

105

(21494755) Public health laboratory ask at order entry panel

210

0.95

0.04

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

230

1.05

0.03

1.4

1.6

—

(3026008) Bacteria identified in Urine by Culture

638

1.02

0.03

2.5

2.3

—

(3022145) Colonoscopy Study observation

118

0.93

0.03

1.7

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

249

0.96

0.02

1.4

1.3

131.97

127.52

iu/ml

—

(3006315) Basophils [#/volume] in Blood

111

1121

0.98

0.02

10.5

6.4

0.04

e9/l

0.06

973

(3001604) Monocytes [#/volume] in Blood

111

1120

0.99

0.02

10.5

6.5

0.52

e9/l

0.06

974

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

144

1450

0.99

0.02

2.4

2.3

2.55

2.66

mmol/l

0.99

138

1359

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

143

1440

0.99

0.02

2.4

2.3

1.42

1.43

mmol/l

0.13

138

1357

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.08

0.02

4.3

2.7

1.23

mmol/l

—

(40768797) Stomach Pathology biopsy report

157

0.95

0.01

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

124

1233

1.01

0.01

4.9

3.2

29.40

24.63

u/l

0.33

118

1174

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

166

0.96

0.00

6.3

6.7

23.26

24.40

mmol/l

0.57

166

(3042936) Bacteria identified in Isolate by Culture

184

1.03

0.00

2.1

2.2

—

(3023368) Bacteria identified in Blood by Culture

306

0.98

0.00

5.6

3.6

—

(3027008) Opiates [Presence] in Urine

404

1.02

0.00

1.7

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

514

1.01

0.00

1.3

1.4

91.04

97.29

pmol/l

0.55

277

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

934

1.01

0.00

1.5

1.6

1.35

2.15

u/ml

0.49

200

(3013139) Helicobacter pylori Ag [Presence] in Stool

112

0.98

0.00

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

402

0.99

0.00

1.8

—

(3019225) pH of Specimen

111

0.99

0.00

1.2

3.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

119

1.01

0.00

1.6

1.5

—

(3022096) Basophils/100 leukocytes in Blood

103

1031

1.00

0.00

10.7

6.7

0.54

0.61

0.69

974

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

213

0.98

0.00

2.0

2.7

338.13

793.09

ng/l

—

(3016879) Cocaine [Presence] in Urine

373

0.99

0.00

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

453

0.99

0.00

1.5

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

365

1.02

0.00

4.1

2.7

3.73

1.00

mg/l

0.52

226

(3028300) Cannabinoids [Presence] in Urine

405

1.01

0.00

1.7

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

106

1055

1.01

0.00

10.8

6.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.94

0.00

1.8

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.01

0.00

1.1

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.00

-0.00

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

56.70

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

2.7

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

1.13

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.89

-0.00

1.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

25.93

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

59.33

—

(3006270) Folate [Moles/volume] in Blood

0.00

-0.00

0.0

1.1

—

402.57

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.4

—

9.26

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.00

-0.00

2.6

1.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

-0.00

0.0

2.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.98

-0.00

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

3.8

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

-0.00

0.0

1.6

—

81.36

—

(3045414) Leukocytes [Presence] in Urine

0.92

-0.00

1.9

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.4

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

32.00

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

6.40

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

-0.00

0.0

9.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

-0.00

0.0

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

17.65

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

38.00

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

-0.00

0.0

1.0

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

4.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.00

-0.00

1.2

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

10.60

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.00

-0.00

0.0

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

4.43

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

8.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.6

—

750.40

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

3.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

30.2

—

0.61

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

-0.00

0.0

8.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.4

—

(3049717) Cytology report of Urine Cyto stain

0.00

-0.00

0.0

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_MAXIL_CANINE_PALAT and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_MAXIL_CANINE_PALAT.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: K11_MAXIL_CANINE_PALAT – Palatinal maxillary canine

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Palatinal maxillary canine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints